Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 112, Issue 1, 2004, Pages 65-68

  Suh, Jihyun ^a   Lee, Eunyoung ^b   Hwang, Seongsoo ^b   Yoon, Sarah ^c   Yoon, Byung Koo ^a   Bae, Duksoo ^a   Choi, Dooseok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Maria Infertility Clinics   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Controlled ovarian hyperstimulation (COH); Follicular environment; GnRH agonists (GnRHa); Pregnancy associated plasma protein A (PAPP A)

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; LEPTIN; NAFARELIN ACETATE; PLASMA PROTEIN;

ARTICLE; CLINICAL ARTICLE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0345734432     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00317-8     Document Type: Article

References (22)

1. Parinaud J., Beaur A., Bourreau E., Vieitez G., Pontonnier G. Effect of a luteinizing hormone-releasing hormone agonist (buserelin) on steroidogenesis of cultured human preovulatory granulose cells. Fertil Steril. 50:1988;597-602.
2. Tureck R.W., Mastroianni L. Jr., Blasco L., Strauss J.F. III Inhibition of human granulosa cell progesterone secretion by a gonadotrophin-releasing hormone agonist. J. Clin Endocrinol Metab. 54:1982;1078-1080.
3. Hughes E.G., Fedorkow D.M., Daya S., Sagle M.A., Van de Koppel P., Collins J.A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 58:1992;888-896.
4. Meldrum D.R., Wisot A., Hamilton F., Gutlay A.L., Kempton W.F., Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril. 51:1989;455-459.
5. Feldberg D., Farhi J., Ashkenazi J., Dicker D., Shalev J., Ben-Rafae Z. Minidose gonadotrophin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril. 62:1994;343-346.
6. Pantos K., Meimeth-Damianaki T., Vaxevanoglou T., Kapetanakis E. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilizing program. Fertil Steril. 61:1994;709-713.
7. Elgendy M., Afnan M., Holder R. Reducing the dose of gonadotropin- releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome. Hum Reprod. 13:1998;2382-2385.
8. Dal Prato L., Borini A., Trevisi M.R., Bonu M.A., Sereni E., Flamigni C. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod. 16:2001;1409-1414.
9. Takeuchi S., Minoura H., Shibahara T., Tsuiki Y., Noritaka F., Toyoda N. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 76:2001;532-537.
10. Yuzpe A.A., Nisker J.A., Kaplan B.R., Tummon I.S., Auckland J. Nafarelin acetate for pituitary down-regulation in vitro fertilization; comparison of two dosages. J. Reprod Med. 40:1995;83-88.
11. Erickson G.F., Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil Steril. 76:2001;943-949.
12. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G.et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc. Natl. Acad. Sci. USA. 96:1999;3149-3153.
13. Hourvitz A., Widger A.E., Filho F.L., Chang R.J., Adashi E.Y., Erickson G.F. Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea. J. Clin Endocrinol Metab. 85:2000;4916-4919.
14. Conover C.A., Faessen G.F., Ilg K.E.et al. Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endorinology. 142:2001;2155-2158.
15. Rivera G.M., Chandrasekger Y.A., Evans A.C., Giudice L.C., Fortune J.E. A potential role for insulin-like growth factor binding-4 proteolysis in the establishment of ovarian follicular dominance in cattle. Biol Reprod. 65:2001;102-111.
16. Dirnfeld M., Goldman S., Gonen Y., Koifmen M., Calderon I., Abramovici H. A simplified co-culture system with luteinized granulose cells improves embryo quality and implantation rates: a controlled study. Fertil Steril. 67:1997;120-122.
17. Hourvitz A., Kuwahara A., Hennebold J.D.et al. The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea. Endocrinology. 143:2002;1833-1844.
18. Mazerbourg S., Overgaard M.T., Oxvig C.et al. Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology. 142:2001;5243-5253.
19. Giudice LC. Insulin-like growth factor family in Graafian follicle development and function. J Soc Gynecol Invest 2001(Suppl 1);8:S26-9.
20. Hugues J.N., Cedrin-Durnerin I.C. Revisting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotropins. Hum Reprod Update. 4:1998;83-101.
21. Racowsky C., Prather A.L., Johnson M.K., Olvera S.P., Gelety T.J. Prematurely condensed chromosomes and meiotic abnormalities in unfertilized human oocytes after ovarian stimulation with and without gonadotropin-releasing hormone agonist. Fertil Steril. 67:1997;932-938.
22. Selva J., Martin-Pont B., Hugues J.N.et al. Cytogenetic study of human oocytes uncleaved after in-vitro fertilization. Hum Reprod. 6:1991;709-713.